Syneos Health, Inc. (SYNH) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Jun-30-22	Mar-31-22	Dec-31-21	Jun-30-21	Mar-31-21	Dec-31-20
	10-Q	10-Q	10-Q	10-Q	8-K	10-Q	10-Q	10-K
Revenues:
United States						2,734.6	2,620.5	2,640.0
Other						1,995.8	1,840.7	1,775.8
Revenues						4,730.4	4,461.2	4,415.8
Revenue growth [+]						3.6%	-5.5%	-5.6%
United States						-2.6%	-10.8%	-9.9%
Cost of goods sold						3,606.1	3,419.4	3,398.1
Gross profit						1,124.3	1,041.8	1,017.6
Gross margin						23.8%	23.4%	23.0%
Selling, general and administrative [+]						391.1	495.4	483.7
Sales and marketing						252.4	356.8
General and administrative								138.7
Other operating expenses						252.3	-11.4	-14.9
EBITDA [+]						538.7	557.8	548.9
EBITDA growth						10.4%	7.0%	8.5%
EBITDA margin						11.4%	12.5%	12.4%
Depreciation and amortization						111.8	71.4	70.2
EBITA						426.9	486.4	478.7
EBITA margin						9.0%	10.9%	10.8%
Amortization of intangibles						114.1	152.8	152.2
EBIT [+]						312.8	333.6	326.5
EBIT growth						22.5%	17.5%	24.0%
EBIT margin						6.6%	7.5%	7.4%
Non-recurring items						24.2	28.4	33.4
Interest expense							88.5	91.6
Interest expense							88.5	91.6
Other income (expense), net [+]						30.5	-7.8	2.1
Gain (loss) on debt retirement							-2.2	-1.6
Other							-6.1	3.0
Pre-tax income						252.3	208.9	203.7
Income taxes						16.4	11.0	10.9
Tax rate						6.5%	5.2%
Net income						235.9	197.9	192.8
Net margin						5.0%	4.4%	4.4%

Basic EPS [+]						$2.26	$1.90	$1.85
Growth						25.6%	1.2%	45.9%
Diluted EPS [+]						$2.24	$1.88	$1.83
Growth						25.7%	1.3%	45.6%


Shares outstanding (basic) [+]						104.2	104.2	104.2
Growth						0.2%	0.4%	0.6%
Shares outstanding (diluted) [+]						105.4	105.4	105.5
Growth						0.2%	0.3%	0.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.